Recalls / Active ingredient / Norethindrone Acetate
Norethindrone Acetate
6 FDA drug recalls involving the active ingredient “Norethindrone Acetate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-01-07 | Class III | Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx On | Teva Pharmaceuticals USA |
| 2022-01-07 | Class III | Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx o | Teva Pharmaceuticals USA |
| 2021-07-30 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx | Noven Pharmaceuticals Inc |
| 2021-07-30 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx On | Noven Pharmaceuticals Inc |
| 2017-01-30 | Class III | Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets ( | Mylan Pharmaceuticals Inc. |
| 2013-03-15 | Class III | Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 2 | Teva Pharmaceuticals USA, Inc. |